SPECTRUM PHARMACEUTICALS INC SPPI Income Statement

Spectrum pharmaceuticals inc (SPPI)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Revenues (Note 1(b))
0	0	0	0	0	0	0	0	0	-99,797	36,395	34,301	29,101	35,236	33,393	33,949	43,866	50,329	28,627	44,982	38,618	51,861	47,990	46,855	40,124	41,516	42,439	33,232	38,667	70,104	69,042	68,702	59,859	52,979	51,024	45,362	43,598	16,735	12,343
Operating costs and expenses:
Selling, general and administrative
14,794	15,065	13,126	17,230	15,952	16,575	13,108	16,391	16,616	9,707	18,527	17,421	19,104	19,371	19,465	27,620	21,962	22,766	19,411	22,552	23,335	24,485	24,125	25,399	23,403	25,714	29,003	22,584	22,014	25,388	22,925	23,347	18,262	24,936	15,811	18,699	12,751	11,411	13,802
Research and development
15,993	23,290	17,167	16,982	21,886	29,883	15,314	16,595	13,365	7,764	13,815	15,167	14,779	16,087	13,293	14,281	15,462	15,740	9,924	9,558	15,851	14,410	14,420	11,335	29,497	10,760	13,567	10,460	11,883	13,067	10,019	9,583	8,891	5,758	7,388	7,686	5,830	7,485	6,285
Amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	6,928	6,901	6,889	6,848	6,907	6,306	5,839	10,462	6,919	6,916	14,022	6,525	7,042	5,361	5,360	5,245	4,935	5,449	4,445	4,418	1,834	1,636	930	930	930	930	930	930	930
Total operating costs and expenses
30,787	38,355	30,293	34,212	37,838	46,458	28,422	32,986	29,981	-39,085	51,449	52,910	51,010	53,762	49,389	56,030	50,149	55,149	44,701	45,016	60,279	53,493	52,117	48,251	64,538	48,028	55,726	45,761	45,124	58,104	45,933	46,140	36,756	41,907	32,974	35,445	26,091	23,615	24,609
Loss from continuing operations before other expense and income taxes
-30,787	-38,355	-30,293	-34,212	-37,838	-46,458	-28,422	-32,986	-29,981	-60,712	-15,054	-18,609	-21,909	-18,526	-15,996	-22,081	-6,283	-4,820	-16,074	-34	-21,661	-1,632	-4,127	-1,396	-24,414	-6,512	-13,287	-12,529	-6,457	12,000	23,109	22,562	23,103	11,072	18,050	9,917	17,507	-6,880	-12,266
Other (expense) income:
Interest income, net
704	919	1,521	1,495	1,061	144	-12	-242	-230	-601	-2,014	-2,131	-2,052	-2,347	-2,373	-2,375	-2,340	-2,314	-2,274	-2,258	-2,228	-2,180	-2,361	-1,976	-2,067	-746	-628	-397	-421	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration related to acquisitions
-	-	-	-	-	-	-	-	-	-	-2,942	-97	-197	600	78	-285	-1,042	1,241	81	-146	-500	2,897	-181	-1,005	-724	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,999	-1,237	-5,250	1,629	2,826
Other expense, net
-10,534	-3,344	2,015	3,722	-11,285	-8,004	-40,880	48,492	9,972	-512	251	240	410	-103	372	340	278	252	-535	69	-1,035	-2,129	-1,393	-487	-358	763	1,370	234	-897	717	293	-1,507	138	-270	-144	174	520	578	-236
Total other expense
-9,830	-2,425	3,536	5,217	-10,224	-7,860	-40,892	48,250	9,742	2,123	-4,705	-1,988	-1,839	-1,850	-1,923	-2,320	-3,104	-821	-2,728	-2,335	-3,763	-1,412	-3,935	-3,468	-3,149	2,888	742	-163	-1,318	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations before income taxes
-40,617	-40,780	-26,757	-28,995	-48,062	-54,318	-69,314	15,264	-20,239	-58,589	-19,759	-20,597	-23,748	-20,376	-17,919	-24,401	-9,387	-5,641	-18,802	-2,369	-25,424	-3,044	-8,062	-4,864	-27,563	-3,624	-12,545	-12,692	-7,775	12,232	23,402	21,055	23,241	11,099	20,905	8,854	12,777	-4,673	-9,676
Benefit for income taxes from continuing operations
0	-592	-200	-200	-8,216	-1,101	-100	400	-1,100	-20,529	-1,466	255	-201	-1,677	-464	-106	-66	407	-78	-23	100	-68	3,477	-1,301	78	35,542	-4,733	-2,971	-2,340	4,167	1,878	2,985	-23,301	-	650	1,650	-	-79	-
Loss from continuing operations
-40,617	-40,200	-26,557	-28,783	-39,846	-53,256	-69,172	14,894	-19,172	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from discontinued operations, net of income taxes (Note 10)
45	1,150	572	388	20,587	3,305	454	-1,150	3,356	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-40,572	-39,050	-25,985	-28,395	-19,259	-49,951	-68,718	13,744	-15,816	-29,497	-18,293	-20,852	-23,547	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,594	-9,676
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,455	-24,295	-9,321	-	-18,724	-2,346	-25,562	-	-11,539	-3,563	-27,641	-	-7,812	-9,721	-5,435	-	21,524	18,070	46,542	9,695	20,255	7,204	12,777	-	-
Basic and diluted loss per share:
Loss per common share from continuing operations ($ per share)
-0.36	-	-0.24	-0.26	-0.36	-	-0.66	0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income per common share from discontinued operations ($ per share)
0.00	-	0.01	0.00	0.19	-	0.00	-0.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss per common share from continuing operations (in dollar per share)
-	-	-	-	-	-	-	-	-0.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income per common share from discontinued operations (in dollar per share)
-	-	-	-	-	-	-	-	0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per common share ($ per share)
-0.36	-	-0.23	-0.26	-0.18	-	-0.66	0.13	-	-	-0.22	-0.27	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.09	0.13	0.37	0.31	0.80	0.17	0.38	0.14	0.25	-0.09	-0.20
(Loss) income per common share from continuing operations ($ per share)
-	-	-	-0.26	-	-	-	0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) per common share from discontinued operations ($ per share)
-	-	-	0.00	-	-	-	-0.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Per Share, Diluted
-	-	-	-0.26	-	-	-	0.13	-	-	-0.22	-0.27	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.09	0.13	0.33	0.29	0.71	0.17	0.34	0.12	0.23	-0.09	-0.20
Earnings Per Share, Basic and Diluted
-	-	-	-	-	-	-	-	-0.16	-	-	-	-0.30	-	-0.22	-0.35	-0.14	-	-0.28	-0.04	-0.39	-	-0.18	-0.06	-0.44	-	-0.13	-0.16	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding:
Basic (shares)
111,780	111,266	111,178	110,345	109,552	-	104,106	102,597	-	-	83,463	78,576	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	59,181	58,215	58,912	58,763	58,464	55,726	53,810	52,257	51,297	49,739	49,020
Diluted (shares)
111,780	111,266	111,178	110,345	109,552	-	104,106	112,617	-	-	83,463	78,576	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	59,181	64,763	65,139	63,387	65,258	58,574	59,469	58,265	55,529	49,739	49,020
Basic and Diluted (shares)
-	-	-	-	-	-	-	-	100,809	-	-	-	78,523	-	79,303	68,575	65,597	-	65,855	65,466	64,880	-	64,765	64,609	63,447	-	61,903	58,977	-	-	-	-	-	-	-	-	-	-	-
Product [Member]
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	25,845	32,196	30,272	30,887	35,241	34,837	28,457	35,144	38,413	51,670	47,916	46,855	40,096	40,477	41,439	32,213	29,346	66,710	65,871	65,627	56,784	49,904	47,949	42,287	40,523	13,660	9,268
Cost of sales (excludes amortization of intangible assets)
-	-	-	-	-	-	-	-	-	-	-	-	8,135	9,237	7,503	5,609	5,604	6,181	8,447	5,990	7,071	8,073	6,530	6,156	6,278	6,309	8,221	7,268	6,782	15,231	11,155	11,574	8,673	10,283	8,845	8,130	6,580	3,789	3,592
License and Service [Member]
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	3,256	3,040	3,121	3,062	8,625	15,492	170	9,838	205	191	74	0	28	1,039	1,000	1,019	9,321	3,394	3,171	3,075	3,075	3,075	3,075	3,075	3,075	3,075	3,075
Service [Member]
Cost of Goods and Services Sold
-	-	-	-	-	-	-	-	-	-	-	-	2,103	2,173	2,221	2,214	1,282	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-